AliveDx (Alba Bioscience) supplies laboratories with manual reagents and automated in-vitro diagnostic platforms for autoimmune, allergy and blood-bank testing.
Alba Bioscience Limited, now operating as AliveDx, is an in-vitro diagnostics company that supplies laboratories with reagents and automated platforms for diagnosing autoimmune, allergy, blood-bank and related conditions. Its stated purpose is to simplify laboratory workflows and shorten the time to diagnosis, so that patients receive accurate results and access treatment sooner. The company reports more than 30 years of experience in in-vitro diagnostics; its corporate history began as Alba Bioscience, continued under Quotient and now operates as AliveDx.
Its product portfolio spans three lines. Alba is a manual reagent range covering autoimmune, allergy, blood-bank and related testing. MosaiQ is an automated multiplexing platform for in-vitro diagnostics, and LumiQ is an immunofluorescence system. Technical work across the business covers immunofluorescence, automated multiplexing and manual reagent development.
The company reaches customers internationally through distribution partnerships. Its teams span research and development, manufacturing, quality management, commercial planning and corporate support, with an emphasis on technical expertise, reliable customer service and the provision of scientific insight to the laboratories it serves. The sectors served include clinical laboratories, blood banking and transfusion medicine, and autoimmune and allergy diagnostics.
